Latest filingSep 09, 2026Most recent Form 4
BLTE
BELITE BIO, INC
Insider activity for last month from 08/10 to 09/10. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$3.18B38 sells
Net open-market-$3.18B2 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period38transactions
- S · Open-market sells · dominant38 · 100%
Activity by reported role
A joint filing can contribute to multiple roles38transactions
- Chief executive officer · dominant19 · 50%
- Chief financial officer19 · 50%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (2)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeChuang Hao-YuanAmerican depositary share · Direct
28,600Sep 08, 2026
Lin Yu-HsinAmerican depositary share · Direct
93,734Sep 08, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 10 → Sep 10
LessMore
Top insiders
By absolute net value across the selected period- LY-$19.1M
- CH-$12.8M
Recent filing activity
Most recent 12 transactions · color = transaction codeFiling detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
BLTE transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 2.70k | -$53.4M | S | — | — | 09/09 | 09/08 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 8.75k | -$172M | S | — | — | 09/09 | 09/08 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 6.05k | -$119M | S | — | — | 09/09 | 09/08 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 6.09k | -$119M | S | — | — | 09/09 | 09/08 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 2.40k | -$46.6M | S | — | — | 09/09 | 09/08 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 8.11k | -$156M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 4.20k | -$81.0M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 11.0k | -$211M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 600 | -$11.4M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 8.95k | -$169M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 3.04k | -$57.3M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 6.20k | -$116M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 7.80k | -$145M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 4.59k | -$85.1M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 6.25k | -$115M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 4.95k | -$90.8M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 3.41k | -$62.2M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 2.58k | -$46.8M | S | — | — | 09/09 | 09/04 |
| BLTE | Lin Yu-Hsin | CEO | sale10b5-1 | 2.63k | -$47.5M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 2.56k | -$50.7M | S | — | — | 09/09 | 09/08 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 4.60k | -$90.8M | S | — | — | 09/09 | 09/08 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 4.47k | -$87.9M | S | — | — | 09/09 | 09/08 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 4.12k | -$80.5M | S | — | — | 09/09 | 09/08 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 2.20k | -$42.7M | S | — | — | 09/09 | 09/08 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 4.60k | -$88.8M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 3.39k | -$65.3M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 6.20k | -$118M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 1.80k | -$34.3M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 6.20k | -$117M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 1.90k | -$35.8M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 3.90k | -$72.9M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 4.59k | -$85.7M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 3.87k | -$71.7M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 3.56k | -$65.8M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 3.75k | -$68.8M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 2.00k | -$36.4M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 2.00k | -$36.2M | S | — | — | 09/09 | 09/04 |
| BLTE | Chuang Hao-Yuan | CFO | sale10b5-1 | 1.63k | -$29.4M | S | — | — | 09/09 | 09/04 |
BELITE BIO, INC Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at BELITE BIO, INC?
Lin Yu-Hsin, Chuang Hao-Yuan.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Lin Yu-Hsin reported a sale on Sep 08, 2026 valued at $53.4M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $31,886,076.35. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.